Aslam Anis

Academic Rank(s)

Professor
Director, School of Population and Public Health
Director, Centre for Advancing Health Outcomes

Phone

604-806-8712
604-822-2772

Email

spph.director@ubc.ca

Location

135 – 2206 East Mall Vancouver, BC V6T 1Z3

About
OpenClose

Research Area: cost effectiveness of AIDS treatments; drug assessments – pharmacoeconomics; health care economics; health regulations, Health economics, rhematoid arthritis, biologic therapies

Dr. Aslam Anis is one of Canada’s most distinguished health economists. In a career spanning more than 30 years, he has achieved international recognition for his seminal contributions to the fields of pharmacoeconomics, pharmaceutical industry regulation, and drug pricing. Dr. Anis’ current and past work is influential across a broad spectrum of health research domains including HIV/AIDS, rheumatoid arthritis, substance use and addiction treatment, among others. He has published over 250 peer-reviewed manuscripts and regularly presents at national and international conferences as an expert in his field.

Dr. Anis has also developed a reputation for leadership and administrative excellence. He is a key architect for the continuing success of the Canadian HIV Trials Network (CTN) and the Centre for Advancing Health Outcomes, where he has made remarkable contributions to the health sciences and further established himself as one of the pre-eminent health economists in Canada and internationally.

Awards
OpenClose

2010: Fellow of the Canadian Academy of Health Scientists

2022:  Faculty of Medicine Distinguished Researcher Award 

Professional Affiliations
OpenClose

National Director, CIHR Canadian HIV Trials Network
Director, School of Population and Public Health, UBC
Senior Scientist, Arthritis Research Canada
Centre Director, Centre for Advancing Health Outcomes

Research
OpenClose
  • Cost-effectiveness of new drugs
  • Impact of regulations on the pharmaceutical industry
  • HIV/AIDS
  • Arthritis
  • ObesityHis primary areas of research involvement include health services research, measuring patient-reported outcomes, clinical trials including pragmatic and pharmacoeconomic trials, Canadian competition policy in the pharmaceutical industry, and the cost-effectiveness of treatments for HIV/AIDS, rheumatoid arthritis, and other conditions.
Teaching
OpenClose

SPPH 546: Introduction to Health Economics